Ingen internetforbindelse — viser den gemte version af siden.

NEKTAR THERAPEUTI…

USUSD
← Til Screeneren

NEKTAR THERAPEUTICS (LSE:0UNL) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
nektar.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
San Francisco, United States
Administrerende Direktør
Howard W. Robin
Ansatte
63
Grundlagt
1990
Udestående Aktier
34.14 mio. pr. 2026-08-07
Free Float
28.28 mio.
Markedsværdi
1.49 mia. USD
Insidere
0.38%
Institutionelle Investorer
107.69%
Branche (SIC)
Pharmaceutical Preparations
ISIN
US6402683063
LEI
5299005I24806IOIYE03
FCF
−234 mio. USD
Gæld
255 mio. USD
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksNKTR primærUSD37.92 -4.82%almindelige aktier
LSE London Stock Exchange0UNL IOBUSD44.2 +0.00%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største Ejere

EjerAndelAktierRapportdato
FMR, LLC14.84%5.07 mio.2026-06-30
Two Seas Capital Lp9.06%3.09 mio.2026-06-30
Blackrock Inc.8.62%2.94 mio.2026-06-30
BVF Inc.7%2.39 mio.2026-06-30
Fidelity Mt. Vernon Stre…5.36%1.83 mio.2026-07-31
Vanguard Capital Managem…4.38%1.5 mio.2026-06-30
Two Sigma Investments, L…3.52%1.2 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.15%1.08 mio.2026-06-30
Vestal Point Capital, LP2.93%1 mio.2026-06-30
Morgan Stanley2.74%936 5602026-06-30
State Street Corporation2.66%909 6792026-06-30
iShares Trust-iShares Ru…2.59%882 6712026-08-31
Geode Capital Management…2.58%881 3062026-06-30
Fidelity Mt. Vernon Stre…1.45%495 0432026-07-31
Fidelity Mt. Vernon Stre…1.23%419 8232026-07-31
VANGUARD INDEX FUNDS-Van…1.14%387 5712026-06-30
Fidelity Salem Street Tr…1.1%376 8922026-07-31
iShares Trust-iShares Ru…0.85%289 5332026-08-31
PRIMECAP Odyssey Funds-P…0.5%172 4192026-07-31
Fidelity Concord Street…0.49%166 5772026-07-31
ROBIN HOWARD W (Chief Ex…≈0.16%54 6552026-08-18
WILSON MARK ANDREW (Offi…≈0.06%21 5852025-11-25
ZALEVSKY JONATHAN (Offic…≈0.03%9 5702026-08-18